GOSS
Gossamer Bio Inc.
$2.45
+$0.03(+1.24%)
49
Overall
40
Value
58
Tech
--
Quality
Market Cap
$693.51M
Volume
2.16M
52W Range
$0.66 - $3.60
Target Price
$9.00
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | -- | -- | -- | -- | -- | $114.7M | ||
| Total Revenue | -- | -- | -- | -- | -- | $114.7M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | -- | -- | -- | -- | -- | $114.7M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $186.1M | $234.0M | $216.1M | $218.6M | $183.8M | $174.6M | ||
| Research & Development | $147.0M | $184.2M | $170.3M | $170.9M | $135.3M | $138.5M | ||
| Research Expense | $147.0M | $184.2M | $170.3M | $170.9M | $135.3M | $138.5M | ||
| Selling, General & Administrative | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
| General & Administrative Expenses | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
| Salaries & Wages | -- | -- | -- | $42.6M | $28.5M | $20.6M | ||
| Depreciation & Amortization | $900.0K | $1.4M | $1.7M | $1.8M | $1.6M | $800.0K | ||
| Depreciation & Amortization | $900.0K | $1.4M | $1.7M | $1.8M | $1.6M | $800.0K | ||
| Other Operating Expenses | $-2.3M | $-2.3M | $-2.5M | $-3.0M | $-3.1M | $-2.3M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-186.1M | $-234.0M | $-216.1M | $-218.6M | $-183.8M | $-59.9M | ||
| EBITDA | $-177.4M | $-226.4M | $-209.4M | $-209.9M | $-174.1M | $-50.4M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $1.9M | $12.7M | $19.4M | $13.9M | $13.5M | -- | ||
| Intinc | -- | -- | -- | $1.6M | $2.0M | $1.8M | ||
| Net Non-Operating Interest Income/Expense | $-1.9M | $-12.7M | $-19.4M | $12.3M | $2.0M | $1.8M | ||
| Other Income/Expense | $-7.8M | $-3.3M | $-1.6M | $1.4M | $-15.5M | $-14.0M | ||
| Other Special Charges | $7.8M | $3.3M | $1.6M | $1.5M | $15.5M | $14.0M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-178.4M | $-230.7M | $-214.6M | $-215.5M | $-179.8M | $-55.6M | ||
| Pre-Tax Income | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-55.6M | ||
| INCOME TAX | ||||||||
| Tax Provision | -- | -- | -- | -- | -- | $893.0K | ||
| NET INCOME | ||||||||
| Net Income | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
| Net Income (Continuing Operations) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
| Net Income (Discontinued Operations) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
| Net Income (Common Stockholders) | $-180.3M | $-243.4M | $-234.0M | $-229.4M | $-179.8M | $-56.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | $-55.1M | ||
| TOTALS | ||||||||
| Total Expenses | $186.1M | $234.0M | $216.1M | $218.6M | $183.8M | $174.6M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $54.7M | $68.5M | $74.8M | $84.6M | $152.6M | $226.2M | ||
| Average Shares Outstanding (Diluted) | $54.7M | $68.5M | $74.8M | $84.6M | $152.6M | $226.2M | ||
| Shares Outstanding | $66.3M | $75.5M | $76.5M | $95.0M | $225.6M | $227.2M | ||
| Basic EPS | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
| Basic EPS (Continuing Operations) | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
| Diluted EPS | $-3.29 | $-3.55 | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-3.13 | $-2.71 | $-1.18 | $-0.25 | ||
| OTHER METRICS | ||||||||
| Other Gand A | $39.1M | $49.7M | $45.8M | $47.6M | $38.5M | $36.1M | ||
| Rent And Landing Fees | $3.1M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GOSS | $2.45 | +1.2% | 2.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |